ReviewTherapeutic advances in cardiovascular disease2016

Factor Xa inhibitors: a novel therapeutic class for the treatment of nonvalvular atrial fibrillation.

Delilah McCarty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.